person
Eduardo C. Á.
- Country
- Spain
- Department
- Oncology
Research Overview
assignment
23
Clinical Trials ·
- Phase 1 Study of SHP2 Inhibitor BBP-398 and KRAS-G12C Inhibitor Sotorasib in Advanced Solid Tumors with KRAS-G12C Mutation
- Evaluation of MEDI5752 in Patients with Advanced Solid Tumors: A Clinical Trial
- Phase I Open-label Dose-escalation Study of Intravenous PM14 in Patients with Advanced Solid Tumors
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
123
Sites with multiple studies
Has run more than one trial at 123 of 299 partner sites.
Specializations
Oncology Focus
Specializes in clinical research involving advanced solid tumors and metastatic cancers, with particular emphasis on investigating novel therapeutic approaches.
- Lung Cancer Research
- Melanoma Studies
- Colorectal Cancer
- Gastric Cancer
Immunotherapy Expertise
Focuses on developing and evaluating immunotherapy treatments, particularly involving monoclonal antibodies and combination therapies.
- PD-1/PD-L1 Inhibitors
- T-Cell Stimulation
- Combination Immunotherapy
Targeted Therapies
Investigates precision medicine approaches for specific genetic mutations and molecular targets in cancer treatment.
- KRAS Mutation Studies
- HER2 Targeted Therapies
- BRAF-V600 Research
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.